Login / Signup

MUM1 Expression versus Hans Algorithm to Predict Prognosis in Indonesian Diffuse Large B-Cell Lymphoma Patients Receiving R-CHOP.

Cosphiadi IrawanMartha IskandarAgnes Stephanie HarahapCleopas Martin RumendeMaria Francisca Ham
Published in: Cancer management and research (2022)
MUM1 expression of 50% or more can help predict prognosis in DLBCL patients receiving R-CHOP therapy and can be considered as for use as a single marker to predict prognosis.
Keyphrases
  • diffuse large b cell lymphoma
  • epstein barr virus
  • poor prognosis
  • machine learning
  • binding protein
  • deep learning